<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.intarchmed.com/feeds/mostaccessed/journal?quantity=&amp;format=rss&amp;version=">
        <title>International Archives of Medicine - Most accessed articles</title>
        <link>http://www.intarchmed.com</link>
        <description>The most accessed research articles published by International Archives of Medicine</description>
        <dc:date>2010-02-05T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.intarchmed.com/content/3/1/4" />
                                <rdf:li rdf:resource="http://www.intarchmed.com/content/3/1/1" />
                                <rdf:li rdf:resource="http://www.intarchmed.com/content/2/1/37" />
                                <rdf:li rdf:resource="http://www.intarchmed.com/content/3/1/2" />
                                <rdf:li rdf:resource="http://www.intarchmed.com/content/3/1/3" />
                                <rdf:li rdf:resource="http://www.intarchmed.com/content/2/1/38" />
                                <rdf:li rdf:resource="http://www.intarchmed.com/content/2/1/40" />
                                <rdf:li rdf:resource="http://www.intarchmed.com/content/2/1/35" />
                                <rdf:li rdf:resource="http://www.intarchmed.com/content/2/1/36" />
                                <rdf:li rdf:resource="http://www.intarchmed.com/content/2/1/39" />
                            </rdf:Seq>
        </items>
        <extra:info rdf:parseType="Literal">
            <html:div style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif" xmlns:html="http://www.w3.org/1999/xhtml">
                <html:span style="font-weight:bold">
                    This is an RSS newsfeed from BioMed Central
                </html:span>
                <html:br />
                <html:span style="font-size: 12px;">
                    It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit
                    <html:br />
                    <html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">
                        http://www.biomedcentral.com/info/about/rss/
                    </html:a>
                    <html:br />
                </html:span>
            </html:div>
        </extra:info>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.intarchmed.com/content/3/1/4">
        <title>Mutation of mitochondria genome: trigger of somatic cell transforming to cancer cell </title>
        <description>Nearly 80 years ago, scientist Otto Warburg originated a hypothesis that the cause of cancer is primarily a defect in energy metabolism. Following studies showed that mitochondria impact carcinogenesis to remodel somatic cells to cancer cells through modifying the genome, through maintenance the tumorigenic phenotype, and through apoptosis. And the Endosymbiotic Theory explains the origin of mitochondria and eukaryotes, on the other hands, the mitochondria also can fall back. Compared to chromosome genomes, the mitochondria genomes were not restricted by introns so they were mutated(fall back) easy. The result is that mitochondria lose function and internal environment of somatic cell become acid and evoked chromosome genomes to mutate, in the end somatic cells become cancer cells. It is the trigger of somatic cell transforming to cancer cell that mitochondria genome happen mutation and lose function.</description>
        <link>http://www.intarchmed.com/content/3/1/4</link>
                <dc:creator>Du Jianping</dc:creator>
                <dc:source>International Archives of Medicine 2010, 3:4</dc:source>
        <dc:date>2010-02-05T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1755-7682-3-4</dc:identifier>
        <prism:publicationName>International Archives of Medicine</prism:publicationName>
        <prism:issn>1755-7682</prism:issn>
        <prism:volume>3</prism:volume>
        <prism:startingPage>4</prism:startingPage>
        <prism:publicationDate>2010-02-05T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.intarchmed.com/content/3/1/1">
        <title>Biomarkers in psychiatry: drawbacks and potential for misuse</title>
        <description>For more than 20 years, researchers have attempted to identify diagnostic and prognostic biomarkers for psychiatric disorders including schizophrenia, major (unipolar) depression, and bipolar disorder. Advocates of this research contend that identifying such biomarkers will aid in the diagnosis of these disorders, as well as the possible development of effective psychiatric medications to treat them. Currently, there are no diagnostic tests available. This is largely due to the multi-factorial nature of psychiatric disorders. Biomarker testing of individuals is also prohibitively expensive because significant expertise is required to conduct tests and follow-up counseling for the patient is often necessary. It is cautioned that widespread biomarker testing could lead to negative consequences such as discrimination in health insurance and employment, as well as selective abortion.</description>
        <link>http://www.intarchmed.com/content/3/1/1</link>
                <dc:creator>Shaheen Lakhan</dc:creator>
                <dc:creator>Karen Vieira</dc:creator>
                <dc:creator>Elissa Hamlat</dc:creator>
                <dc:source>International Archives of Medicine 2010, 3:1</dc:source>
        <dc:date>2010-01-12T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1755-7682-3-1</dc:identifier>
        <prism:publicationName>International Archives of Medicine</prism:publicationName>
        <prism:issn>1755-7682</prism:issn>
        <prism:volume>3</prism:volume>
        <prism:startingPage>1</prism:startingPage>
        <prism:publicationDate>2010-01-12T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.intarchmed.com/content/2/1/37">
        <title>Acute perimyocarditis mimicking transmural myocardial infarction</title>
        <description>Although acute pericarditis has charachteristic electrocardiographic (ECG) findings that differentiate it from acute ST segment elevation myocardial infarction (MI); in certain cases diagnosis is somewhat difficult especially when the ECG reveals focal instead of diffuse changes and moreover when pericarditis is associated with an underlying myocarditis causing elevation of the cardiac biomarkers therefore increasing the difficulty in differentiating between both enteties. This is especially important because adverse lethal side effect can occur if thrombolytic therapy is administered for a patient with acute pericarditis, or if a diagnosis of transmural MI is missed. In this case report we are describing an 18 year old male patient who presented with an acute onset of severe chest pain associated with focal ECG changes and elevated cardiac enzymes mimicking transmural MI. This report aims to sensitize readers to this debate and create awareness among cardiologists and intensivists with both presentations and how to reach an accurate diagnosis.</description>
        <link>http://www.intarchmed.com/content/2/1/37</link>
                <dc:creator>Hesham Omar</dc:creator>
                <dc:creator>Ahmed Fathy</dc:creator>
                <dc:creator>Rania Rashad</dc:creator>
                <dc:creator>Mohamed Elghonemi</dc:creator>
                <dc:source>International Archives of Medicine 2009, 2:37</dc:source>
        <dc:date>2009-12-09T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1755-7682-2-37</dc:identifier>
        <prism:publicationName>International Archives of Medicine</prism:publicationName>
        <prism:issn>1755-7682</prism:issn>
        <prism:volume>2</prism:volume>
        <prism:startingPage>37</prism:startingPage>
        <prism:publicationDate>2009-12-09T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.intarchmed.com/content/3/1/2">
        <title>Cardiac baroreflex is already blunted in eight weeks old spontaneously hypertensive rats</title>
        <description>Background:
The literature did not evidence yet with which age spontaneously hypertensive rats (SHR) start to present baroreflex reduction. We endeavored to evaluate the baroreflex function in eight-week-old SHR.
Methods:
Male Wistar Kyoto (WKY) normotensive rats and SHR aged eight weeks were studied. Baroreflex was calculated as the variation of heart rate (HR) divided by the mean arterial pressure (MAP) variation (&#916;HR/&#916;MAP) tested with a depressor dose of sodium nitroprusside (SNP, 50 &#956;g/kg) and with a pressor dose of phenylephrine (PHE, 8 &#956;g/kg) in the right femoral venous approach through an inserted cannula in the animals. Significant differences for p &lt; 0.05.
Results:
Baseline MAP (p &lt; 0.0001) and HR (p = 0.0028) was higher in SHR. Bradycardic peak was attenuated in SHR (p &lt; 0.0001), baroreflex gain tested with PHE was also reduced in the SHR group (p = 0.0012). PHE-induced increase in MAP was increased in WKY compared to SHR (p = 0.039). Bradycardic reflex responses to intravenous PHE was decreased in SHR (p &lt; 0.0001).
Conclusion:
Eight weeks old SHR already presents impairment of the parasympathetic component of baroreflex.</description>
        <link>http://www.intarchmed.com/content/3/1/2</link>
                <dc:creator>Jose Cisternas</dc:creator>
                <dc:creator>Vitor Valenti</dc:creator>
                <dc:creator>Thales Alves</dc:creator>
                <dc:creator>Celso Ferreira</dc:creator>
                <dc:creator>Marcio Petenusso</dc:creator>
                <dc:creator>Joao Breda</dc:creator>
                <dc:creator>Adilson Pires</dc:creator>
                <dc:creator>Nadir Tassi</dc:creator>
                <dc:creator>Luiz Carlos de Abreu</dc:creator>
                <dc:source>International Archives of Medicine 2010, 3:2</dc:source>
        <dc:date>2010-01-27T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1755-7682-3-2</dc:identifier>
        <prism:publicationName>International Archives of Medicine</prism:publicationName>
        <prism:issn>1755-7682</prism:issn>
        <prism:volume>3</prism:volume>
        <prism:startingPage>2</prism:startingPage>
        <prism:publicationDate>2010-01-27T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.intarchmed.com/content/3/1/3">
        <title>Treatment of large proximal ureteral stones:
extra corporeal shock wave lithotripsy versus semi-rigid ureteroscope with lithoclast
</title>
        <description>PurposeAssessment of safety and efficacy of extracorporeal shockwave lithotripsy versus semi-rigid ureteroscope with lithoclast for treatment of large proximal ureteral stones.Materials and methodsThe study included 147 patients with large upper ureteral stones. SWL and ureteroscopy were performed in 71 and 76 patients respectively. Patients in the SWL group were treated with Siemens: - Modularis lithovario under intravenous sedation on an out patient basis. Patients in the ureteroscopy group were treated with (7.5 Fr) semi-rigid ureteroscope and lithoclast under spinal anesthesia on a day care basis.
Results:
Stone - free rate for in situ SWL was 58% (41 of 71) patients. For semi-rigid ureteroscope accessibility of the stones was 94% (72 of 76) and the stone free rate was 92% (70 of 76) No major complications were encountered in both groups.Mean stone size was 1.34 &#177; 0.03 cm in the SWL group and 1.51 &#177; 0.04 in the ureteroscopy group.
Conclusions:
Our study demonstrates that ureteroscopy with lithoclast can be considered as acceptable treatment modality for large proximal ureteral calculi and can be considered as fist line for treatment of large proximal ureteral stones.</description>
        <link>http://www.intarchmed.com/content/3/1/3</link>
                <dc:creator>Ehab Tawfiek</dc:creator>
                <dc:source>International Archives of Medicine 2010, 3:3</dc:source>
        <dc:date>2010-01-28T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1755-7682-3-3</dc:identifier>
        <prism:publicationName>International Archives of Medicine</prism:publicationName>
        <prism:issn>1755-7682</prism:issn>
        <prism:volume>3</prism:volume>
        <prism:startingPage>3</prism:startingPage>
        <prism:publicationDate>2010-01-28T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.intarchmed.com/content/2/1/38">
        <title>Diaphragmatic hernia with strangulated loop of bowel presenting after colonoscopy: case report</title>
        <description>Background:
The incidence of diaphragmatic hernias caused or exacerbated by diagnostic colonoscopy is not well elucidated at this time, and is believed to be very rare.Case PresentationWe present the case of a 57 year old man with remote history of traumatic injury who first presented with vague left shoulder pain for two weeks, mild anemia, and tested positive for fecal occult blood. Four days post colonoscopy the patient was found to have a strangulated loop of bowel herniated through the diaphragm into the left hemithorax.
Conclusions:
In patients with previous history of serious traumatic injury and particularly those with previous splenectomy, a thorough history and physical examination before routine colonoscopy is important. A high level of suspicion for post-operative complications should also be maintained when assessing such patients.</description>
        <link>http://www.intarchmed.com/content/2/1/38</link>
                <dc:creator>Sandeep Sodhi</dc:creator>
                <dc:creator>Loren Zech</dc:creator>
                <dc:creator>Vijay Batura</dc:creator>
                <dc:creator>Sampath Kulasekhar</dc:creator>
                <dc:source>International Archives of Medicine 2009, 2:38</dc:source>
        <dc:date>2009-12-11T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1755-7682-2-38</dc:identifier>
        <prism:publicationName>International Archives of Medicine</prism:publicationName>
        <prism:issn>1755-7682</prism:issn>
        <prism:volume>2</prism:volume>
        <prism:startingPage>38</prism:startingPage>
        <prism:publicationDate>2009-12-11T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.intarchmed.com/content/2/1/40">
        <title>Heartburn or angina? Differentiating gastrointestinal disease in primary care patients presenting with chest pain: a cross sectional diagnostic study </title>
        <description>Background:
Gastrointestinal (GI) disease is one of the leading aetiologies of chest pain in a primary care setting. The aims of the study are to describe clinical characteristics of GI disease causing chest pain and to provide criteria for clinical diagnosis.
Methods:
We included 1212 consecutive patients with chest pain aged 35 years and older attending 74 general practitioners (GPs). GPs recorded symptoms and findings of each patient and provided follow up information. An independent interdisciplinary reference panel reviewed clinical data of each patient and decided about the aetiology of chest pain. Multivariable regression analysis was performed to identify clinical predictors that help to rule in or out the diagnosis of GI disease and Gastroesophageal Reflux Disease (GERD).
Results:
GI disease was diagnosed in 5.8% and GERD in 3.5% of all patients. Most patients localised the pain retrosternal (71.8% for GI disease and 83.3% for GERD). Pain worse with food intake and retrosternal pain radiation were associated positively with both GI disease and GERD; retrosternal pain localisation, vomiting, burning pain, epigastric pain and an average pain episode &lt; 1 hour were associated positively only with GI disease. Negative associations were found for localized muscle tension (GI disease and GERD) and pain getting worse on exercise, breathing, movement and pain location on left side (only GI disease).
Conclusions:
This study broadens the knowledge about the diagnostic accuracy of selected signs and symptoms for GI disease and GERD and provides criteria for primary care practitioners in rational diagnosis.</description>
        <link>http://www.intarchmed.com/content/2/1/40</link>
                <dc:creator>Stefan Bosner</dc:creator>
                <dc:creator>Jorg Haasenritter</dc:creator>
                <dc:creator>Annette Becker</dc:creator>
                <dc:creator>Maren Hani</dc:creator>
                <dc:creator>Heidi Keller</dc:creator>
                <dc:creator>Andreas Sonnichsen</dc:creator>
                <dc:creator>Konstantinos Karatolios</dc:creator>
                <dc:creator>Juergen Schaefer</dc:creator>
                <dc:creator>Erika Baum</dc:creator>
                <dc:creator>Norbert Donner-Banzhoff</dc:creator>
                <dc:source>International Archives of Medicine 2009, 2:40</dc:source>
        <dc:date>2009-12-12T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1755-7682-2-40</dc:identifier>
        <prism:publicationName>International Archives of Medicine</prism:publicationName>
        <prism:issn>1755-7682</prism:issn>
        <prism:volume>2</prism:volume>
        <prism:startingPage>40</prism:startingPage>
        <prism:publicationDate>2009-12-12T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.intarchmed.com/content/2/1/35">
        <title>Hypercalcemia in a patient with cholangiocarcinoma: a case report</title>
        <description>Background:
Humoral hypercalcemia of malignancy is rarely associated with cholangiocarcinoma (CC).Case reportA 77-year-old man was admitted with confusion. Computer tomography showed a large multinodular mass in the right lobe of the liver and smaller lesions in the right lung. Liver histology confirmed the diagnosis of CC. Elevated calcium levels and suppressed intact parathyroid hormone in the absence of skeletal metastases or parathyroid gland pathology suggested the diagnosis of humoral hypercalcemia of malignancy (HHM). Treatment of hypercalcemia with saline infusion, loop diuretics, biphosphonate and calcitonin was effective in normalizing calcium levels and consciousness state within 48 hours, but a relapse occurred 4 weeks later and the patient succumbed to his disease.
Conclusion:
Clinicians should be aware of this rare manifestation of CC as prompt and aggressive correction of hypercalcemia alleviates symptoms and improves patient&apos;s quality of life, despite the poor overall prognosis.</description>
        <link>http://www.intarchmed.com/content/2/1/35</link>
                <dc:creator>Ioannis Xynos</dc:creator>
                <dc:creator>Stavros Sougioultzis</dc:creator>
                <dc:creator>Athanasios Zilos</dc:creator>
                <dc:creator>Konstantinos Evagellou</dc:creator>
                <dc:creator>Gregorios Hatzis</dc:creator>
                <dc:source>International Archives of Medicine 2009, 2:35</dc:source>
        <dc:date>2009-10-30T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1755-7682-2-35</dc:identifier>
        <prism:publicationName>International Archives of Medicine</prism:publicationName>
        <prism:issn>1755-7682</prism:issn>
        <prism:volume>2</prism:volume>
        <prism:startingPage>35</prism:startingPage>
        <prism:publicationDate>2009-10-30T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.intarchmed.com/content/2/1/36">
        <title>Family Medicine, the specialty of the future: the Portuguese situation within the European context</title>
        <description>General Practice/Family Medicine is a specialty focused on the provision of comprehensive, continuing, and community oriented, person-centred care. The lack of prestige and the difficulty in attracting trainees to the specialty have been longstanding problems in most countries around the world. In Europe, General Practice/Family Medicine is also hampered for not being recognized as a specialty throughout Europe. As for Portugal, General Practice/Family Medicine is undergoing a massive organizational reform, as well as unprecedented levels of popularity among trainees.General Practice/Family holds tremendous latent potential, and is thus a specialty with a bright future ahead. It could well establish itself as the specialty of the future if it is able to overcome the barriers that currently make of General Practice/Family Medicine an unpopular career choice. It is important to train confident, competent and polyvalent family physicians, but it is also necessary to overhaul payment schemes, to invest in primary care infra-structure and organization, and to continue to attract more and more bright and motivated trainees.</description>
        <link>http://www.intarchmed.com/content/2/1/36</link>
                <dc:creator>Tiago Villanueva</dc:creator>
                <dc:source>International Archives of Medicine 2009, 2:36</dc:source>
        <dc:date>2009-11-11T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1755-7682-2-36</dc:identifier>
        <prism:publicationName>International Archives of Medicine</prism:publicationName>
        <prism:issn>1755-7682</prism:issn>
        <prism:volume>2</prism:volume>
        <prism:startingPage>36</prism:startingPage>
        <prism:publicationDate>2009-11-11T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.intarchmed.com/content/2/1/39">
        <title>Short-term and long-term success of electrical cardioversion in atrial fibrillation in managed care system</title>
        <description>Background:
Initial success of electrical cardioversion (ECV) of atrial fibrillation (AF) has been reported in several studies as 50%-90%, of which only 50% patients remain in sinus rhythm (SR) at the end of one year. We conducted this study to see if outcomes of other trials are applicable in managed care setting.
Methods:
We conducted a retrospective study in 370 consecutive patients who underwent ECV for AF. They were reviewed for initial outcome of ECV and recurrence of AF after a successful ECV, with and without prophylactic antiarrhythmic drugs.
Results:
Initial success of ECV for AF was 65.7%. At one year, 47% remained in SR. AF for &#8804; 3 months (p = 0.006) and pretreatment with antiarrhythmic drugs (p = 0.032) resulted in improved success. Predictors of recurrence were patients &#8804; 65 years (p = 0.019), paroxysmal atrial fibrillation (PAF) (p = 0.0094) and alcohol consumption (p = 0.0074).
Conclusion:
Shorter duration of AF, prophylactic antiarrhythmic drugs and serial ECVs improve outcome of ECV in AF. For younger patients with PAF and alcohol consumption, due to higher recurrence of AF, rate control or ablative therapy may be the preferred strategy.</description>
        <link>http://www.intarchmed.com/content/2/1/39</link>
                <dc:creator>Suman Kuppahally</dc:creator>
                <dc:creator>Elyse Foster</dc:creator>
                <dc:creator>Stanford Shoor</dc:creator>
                <dc:creator>Anthony Steimle</dc:creator>
                <dc:source>International Archives of Medicine 2009, 2:39</dc:source>
        <dc:date>2009-12-12T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1755-7682-2-39</dc:identifier>
        <prism:publicationName>International Archives of Medicine</prism:publicationName>
        <prism:issn>1755-7682</prism:issn>
        <prism:volume>2</prism:volume>
        <prism:startingPage>39</prism:startingPage>
        <prism:publicationDate>2009-12-12T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>
